Mary McKenney

2.0k total citations · 1 hit paper
11 papers, 871 citations indexed

About

Mary McKenney is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Mary McKenney has authored 11 papers receiving a total of 871 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 9 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Mary McKenney's work include Multiple Myeloma Research and Treatments (10 papers), Protein Degradation and Inhibitors (6 papers) and Cancer Treatment and Pharmacology (5 papers). Mary McKenney is often cited by papers focused on Multiple Myeloma Research and Treatments (10 papers), Protein Degradation and Inhibitors (6 papers) and Cancer Treatment and Pharmacology (5 papers). Mary McKenney collaborates with scholars based in United States and Italy. Mary McKenney's co-authors include Kenneth C. Anderson, Paul G. Richardson, Teru Hideshima, Robert Schlossman, Deborah Doss, Edie Weller, Constantine S. Mitsiades, Rebecca L. Rich, Richard LeBlanc and Joan J. Ryoo and has published in prestigious journals such as Journal of Clinical Oncology, Blood and European Journal Of Haematology.

In The Last Decade

Mary McKenney

10 papers receiving 831 citations

Hit Papers

Immunomodulatory drug CC-... 2002 2026 2010 2018 2002 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma
    2002 630 citations Paul G. Richardson, Robert Schlossman et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary McKenney United States 8 769 655 411 124 59 11 871
Tommasina Guglielmelli Italy 13 710 0.9× 589 0.9× 441 1.1× 124 1.0× 78 1.3× 31 879
Kathleen Kelly United States 4 567 0.7× 452 0.7× 298 0.7× 111 0.9× 47 0.8× 6 664
Marcy K. Vallone United States 8 466 0.6× 748 1.1× 335 0.8× 83 0.7× 77 1.3× 14 904
Kelly Godby United States 11 695 0.9× 501 0.8× 435 1.1× 99 0.8× 44 0.7× 52 789
Valeria Magarotto Italy 12 565 0.7× 669 1.0× 345 0.8× 61 0.5× 47 0.8× 32 837
Jessica Anderson United States 3 682 0.9× 765 1.2× 406 1.0× 137 1.1× 103 1.7× 5 1.0k
Mamoun Dib France 9 644 0.8× 459 0.7× 341 0.8× 75 0.6× 25 0.4× 14 696
Jeana Cromer United States 6 802 1.0× 557 0.9× 413 1.0× 64 0.5× 21 0.4× 6 870
Anita Zahlten‐Kumeli United States 11 826 1.1× 711 1.1× 548 1.3× 97 0.8× 60 1.0× 24 995
Jon Ukropec United States 17 1.1k 1.4× 731 1.1× 665 1.6× 198 1.6× 62 1.1× 44 1.2k

Countries citing papers authored by Mary McKenney

Since Specialization
Citations

This map shows the geographic impact of Mary McKenney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary McKenney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary McKenney more than expected).

Fields of papers citing papers by Mary McKenney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary McKenney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary McKenney. The network helps show where Mary McKenney may publish in the future.

Co-authorship network of co-authors of Mary McKenney

This figure shows the co-authorship network connecting the top 25 collaborators of Mary McKenney. A scholar is included among the top collaborators of Mary McKenney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary McKenney. Mary McKenney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Nadeem, Omar, Paul G. Richardson, Jacob P. Laubach, et al.. (2020). Clinical Outcomes of Non-Traditional Lenalidomide, Bortezomib, and Dexamethasone Regimens in Multiple Myeloma. Blood. 136(Supplement 1). 25–26. 1 indexed citations
2.
Guidetti, Anna, Jacob P. Laubach, Cindy Varga, et al.. (2014). Pomalidomide for the treatment of relapsed and refractory multiple myeloma. Expert Opinion on Orphan Drugs. 2(10). 1089–1108. 1 indexed citations
3.
Richardson, Paul G., Jacob P. Laubach, Robert Schlossman, et al.. (2012). The potential benefits of participating in early‐phase clinical trials in multiple myeloma: long‐term remission in a patient with relapsed multiple myeloma treated with 90 cycles of lenalidomide and bortezomib. European Journal Of Haematology. 88(5). 446–449. 8 indexed citations
4.
Richardson, Paul G., Jacob P. Laubach, Constantine Mitsiades, et al.. (2010). Tailoring treatment for multiple myeloma patients with relapsed and refractory disease.. PubMed. 24(3 Suppl 2). 22–9. 10 indexed citations
5.
6.
Richardson, Paul G., Edie Weller, Sundar Jagannath, et al.. (2009). Multicenter, Phase I, Dose-Escalation Trial of Lenalidomide Plus Bortezomib for Relapsed and Relapsed/Refractory Multiple Myeloma. Journal of Clinical Oncology. 27(34). 5713–5719. 127 indexed citations
7.
8.
Richardson, Paul G., Sundar Jagannath, Noopur Raje, et al.. (2007). Lenalidomide, Bortezomib, and Dexamethasone (Rev/Vel/Dex) in Patients with Relapsed or Relapsed/Refractory Multiple Myeloma (MM): Preliminary Results of a Phase II Study.. Blood. 110(11). 2714–2714. 22 indexed citations
9.
Richardson, Paul G., Robert Schlossman, Edie Weller, et al.. (2002). Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma. Blood. 100(9). 3063–3067. 630 indexed citations breakdown →
10.
Richardson, PG, RL Schlossman, Teru Hideshima, et al.. (2001). A phase 1 study of oral CC5013, an immunomodulatory thalidomide (Thal) derivative, in patients with relapsed and refractory multiple myeloma (MM).. Blood. 98(11). 77516. 23 indexed citations
11.
McKenney, Mary. (1975). Divorce: A selected annotated bibliography. Medical Entomology and Zoology. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tommasina Guglielmelli Breakdown of academic impact, for papers by Kathleen Kelly Breakdown of academic impact, for papers by Marcy K. Vallone Breakdown of academic impact, for papers by Kelly Godby Breakdown of academic impact, for papers by Valeria Magarotto Breakdown of academic impact, for papers by Jessica Anderson Breakdown of academic impact, for papers by Mamoun Dib Breakdown of academic impact, for papers by Jeana Cromer Breakdown of academic impact, for papers by Anita Zahlten‐Kumeli Breakdown of academic impact, for papers by Jon Ukropec
Rankless by CCL
2026